RxDoctor Payments Data

Russell Beecher, DO

Physical Medicine & Rehabilitation · Price, UTNPI 1265630941

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.0% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Nevro Corp. at 29.4% of the total.

$4,932in general payments, 2019–2025

Across 263 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$1K
  • Boston Scientific$829
  • Relievant Medsystems, Inc.$609
  • AbbVie$533
  • Collegium Pharmaceutical, Inc.$445
  • Globus Medical$299
  • plus $768 from 15 others

What the payments were for

  • Travel & lodging$4649%
  • Food & beverage$4,44090%
  • Education$281%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,932 in reported general payments places this provider in the 85th percentile of 117 physical medicine & rehabilitation providers in Utah.

See all physical medicine & rehabilitation providers in Utah

Medicare billing

Part B allowed, 2024
$577,734
Medicare patients
781
Services billed
13,274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate53$34,686
Nucynta ErTapentadol Hcl11$18,656
QuliptaAtogepant12$12,605
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen182$6,547
Fentanyl35$5,831
Oxycodone Hcl199$5,644
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen204$5,071
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl24$4,278
Buprenorphine15$3,923
Morphine Sulfate ErMorphine Sulfate134$3,016
Gabapentin173$2,320
Diclofenac Sodium45$1,274
Pregabalin80$1,274
Tizanidine Hcl124$1,271
Morphine Sulfate18$754

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er$445$53,34264 claims
AbbVieQulipta$533$12,60512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 117 physical medicine & rehabilitation providers in Utah.

Other physical medicine & rehabilitation in Price

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →